Drug intelligence / Profile preview

Revervia

Development stage
Unknown
Lead developer
Aker BioMarine
Modality
Small Molecules
Administration
Oral
01

Overview

Revervia is a premium, plant-based nutraceutical ingredient developed by Aker BioMarine, consisting of docosahexaenoic acid (DHA) derived from the microalgae *Schizochytrium sp.* It is produced through a sustainable, solvent-free fermentation process and contains 40-60% DHA in its natural triglyceride form. Marketed as a vegan-friendly alternative to fish oil, Revervia is intended for oral administration as a dietary supplement to support brain health, eye health, and prenatal/pregnancy health. It is primarily sold as a bulk oil to B2B customers for formulation into finished consumer health products, providing a clean-label and sustainable source of essential omega-3 fatty acids.

Brand names
Revervia
Other names
algae-based omega-3Schizochytrium sp. oil
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)PPARA (Peroxisome proliferator-activated receptor alpha)FFAR4 (Free fatty acid receptor 4)

Beyond the preview

Go deeper on Revervia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Revervia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call